All stock lists
Barinthus Biotherapeutics plc. (NASDAQ:BRNS)
US · Delayed Price · Currency is USD
Also listed: VACCHealthcare · Biotechnology
0.74-0.02 (-2.49%)
Insider Score
––Not scored
BRNS Insider Score
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
BRNS Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | -100.00 % | — | — |
| Cost of Revenue | 0.00 | 854.57 K | 907.69 K | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | -854.57 K | -907.69 K | 0.00 | 0.00 | 0.00 |
| SG&A Expense | 7.10 M | 2.53 M | 4.58 M | 5.17 M | 15.38 M | 12.64 M |
| R&D Expense | 3.92 M | 3.59 M | 3.93 M | 5.15 M | 6.61 M | 7.99 M |
| Operating Expenses | 11.02 M | 8.25 M | 8.50 M | 15.07 M | 23.32 M | 20.60 M |
| Operating Income | -11.02 M | -9.11 M | -9.41 M | -15.07 M | -23.32 M | -20.60 M |
| Pretax Income | -10.62 M | -5.69 M | -11.26 M | -14.64 M | -21.15 M | -19.68 M |
| Tax Provision | -23.00 K | -164.72 K | -172.75 K | -71.00 K | -25.00 K | -22.00 K |
| Net Income | -10.58 M | -5.52 M | -11.07 M | -14.57 M | -21.12 M | -19.65 M |
| EPS (Basic) | -0.26 | -0.14 | -0.27 | -0.36 | -0.52 | -0.49 |
| EPS (Diluted) | -0.26 | -0.14 | -0.27 | -0.36 | -0.52 | -0.49 |
| Shares Outstanding | 40.85 M | 40.85 M | 40.53 M | 40.66 M | 40.34 M | 40.27 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.